Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control.
Antiretroviral simplification with darunavir/ritonavir monotherapy in routine clinical practice: safety, effectiveness, and impact on lipid profile.
Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study.
Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitors.
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.
Deep molecular characterization of HIV-1 dynamics under suppressive HAART.
Maraviroc intensification for suboptimal CD4⁺ T cell response in a perinatally HIV-infected adolescent.
European recommendations for the clinical use of HIV drug resistance testing: 2011 update.
A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy.
Can linear regression modeling help clinicians in the interpretation of genotypic resistance data? An application to derive a lopinavir-score.